Stay updated with breaking news from Sera Prognostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The surge in colposcopy device demand is mainly driven by a growing incidence of cervical disorders like cervical cancer and inflammatory...
Los Angeles-based EarlyDiagnostics announced this morning that it has appointed a new, Co-CEO to the company. According to the developer of cancer detection technology, it has appointed Gregory Critchfield as Co-CEO, effective January 1st. The
Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 253,500 shares, an increase of 27.5% from the April 30th total of 198,900 shares. Based on an average daily trading volume, of 180,400 […]
Key Insights Significant control over Sera Prognostics by retail investors implies that the general public has more...
-- Sera Prognostics shares almost tripled after the company said Wednesday it is stopping enrollment in a study evaluating the safety of a preterm birth prevention strategy due to the trial's early...